## **Core Concept**
The question tests knowledge on contrast-induced nephropathy (CIN) prevention, focusing on the choice of contrast agent in patients with decreased renal function. CIN is a significant concern in patients undergoing imaging studies with contrast media, especially those with pre-existing renal impairment. The choice of contrast agent can influence the risk of developing CIN.

## **Why the Correct Answer is Right**
The correct answer, **low-osmolar non-ionic contrast media**, such as iohexol, iopamidol, or ioversol, are preferred in patients with decreased renal function. These agents have been shown to have a lower risk of nephrotoxicity compared to high-osmolar ionic contrast media. Their lower osmolality reduces the osmotic stress on renal tubules, thereby minimizing renal damage. Additionally, non-ionic agents are less likely to cause renal vasoconstriction, which can contribute to CIN.

## **Why Each Wrong Option is Incorrect**
- **Option A:** High-osmolar ionic contrast agents are more nephrotoxic and have largely been replaced by low-osmolar agents for patients with renal impairment due to their higher risk of inducing CIN.
- **Option B:** While some iodinated contrast agents might have specific properties, the broad category of "iodinated contrast agents" does not specifically denote a lower risk of nephrotoxicity; the osmolality and ionic nature are critical factors.
- **Option D:** Gadolinium-based contrast agents are used in MRI and are not typically considered for procedures where iodinated contrast agents are standard, such as CT scans. Moreover, gadolinium deposition disease is a concern with repeated exposure, but it's a different scenario from contrast nephropathy with iodinated agents.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that in patients with decreased renal function, the use of **intravenous hydration** and **N-acetylcysteine** may also be considered alongside the use of low-osmolar non-ionic contrast media to further reduce the risk of CIN. The decision to use these agents should be balanced against the potential benefits of the imaging study.

## **Correct Answer: .**